Glycemic Control, Type II Diabetes, Parathyroidectomy

Description

The purpose of this study is to assess glycemic control after parathyroidectomy in patients with primary hyperparathyroidism and concomitant type 2 diabetes mellitus.

Conditions

Primary Hyperparathyroidism, Type 2 Diabetes

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose of this study is to assess glycemic control after parathyroidectomy in patients with primary hyperparathyroidism and concomitant type 2 diabetes mellitus.

Evaluation of Glycemic Control and Changes in Skeletal Profile in Patients with Type II Diabetes Undergoing Parathyroidectomy for Primary Hyperparathyroidism

Glycemic Control, Type II Diabetes, Parathyroidectomy

Condition
Primary Hyperparathyroidism
Intervention / Treatment

-

Contacts and Locations

Cleveland

Cleveland Clinic Main Campus, Cleveland, Ohio, United States, 44195

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Study group: Consecutive patients older than 18 years old with concomitant PHPT and DM who will undergo PTX. The indications and need for surgery will be independent from the research team.
  • 2. Control group: Consecutive patients older than 18 years old with concomitant PHPT and DM who will not undergo PTX. The indications to forgo surgery will be independent from the research team.
  • 1. Patients with recurrent or persistent PHPT will not be included.
  • 2. Patients who are included but have evidence of recurrent or persistent PHPT based on six-month laboratory workup will be excluded from the final analysis (\<5% expected)9.
  • 3. Patients with type 1 diabetes mellitus
  • 4. Patients with secondary and/or tertiary hyperparathyroidism

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

The Cleveland Clinic,

Judy Jin, MD, PRINCIPAL_INVESTIGATOR, The Cleveland Clinic

Study Record Dates

2026-02-01